Opportunities for Podium, Poster, and Sponsor Presentations at

Cambridge Healthtech Institute’s 23rd Annual

Engineering Antibodies

New Science for Engineering of Next-Generation Biotherapeutics

May 3-4, 2022

 

The field of protein engineering is at an exciting point in its development, with the COVID-19 pandemic bringing new attention to therapeutic antibodies and discovery platforms being deployed under extremely accelerated timelines. New generations of therapeutic antibodies progressing through development and into the market – and a growing body of clinical evidence – is being used to inform development of a next generation of safe and highly effective therapies for unmet medical needs. The popular PEGS Engineering Antibodies conference explores case examples of significant emerging technologies used by protein scientists working at the discovery and design stages to efficiently and creatively design novel biotherapeutics directed at these elusive targets and pathways.   

 

Coverage will include, but is not limited to:

 

Activity-Based Design and Engineering

  • Engineering for challenging modes of action
  • Functional screening combined with cell sorting
  • Selecting for function rather than binding

 

Engineering for Emerging Modalities

  • Antibody-PROTAC conjugates
  • MHC peptide complexes
  • Tri-specific antibodies

 

Problems and Solutions

  • Engineering novel antibody-based conjugates and fusions
  • Using mRNA to deliver coding antibodies
  • Targeting intracellular proteins

 

Structure

  • Applications of Alphafold/Rosettafold in antibody discovery and engineering
  • Engineering applications for Cryo-EM
  • Structure-based antibody design

 

Targeting Membrane Proteins

  • Clinical update on therapeutic antibodies against GPCR and ion channel targets
  • mRNA for targeting membrane protein targets
  • Selection-free optimization for membrane proteins

 

Therapeutic Antibodies for Non-Cancer Indications

  • Antigen discovery for autoimmunity and inflammation
  • Next steps in antibodies for neurodegenerative diseases
  • The impact of Covid research on therapeutic antibodies for infectious diseases

 

The deadline for priority consideration is October 22, 2021.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Kent Simmons

Senior Conference Director

Cambridge Healthtech Institute

Phone: 207-329-2964

Email: ksimmons@healthtech.com

 

For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5452

Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-1340

Email: ashleyparsons@healthtech.com